254 related articles for article (PubMed ID: 27835897)
1. Enhanced circulating transforming growth factor beta 1 is causally associated with an increased risk of hepatocellular carcinoma: a mendelian randomization meta-analysis.
Lu WQ; Qiu JL; Huang ZL; Liu HY
Oncotarget; 2016 Dec; 7(51):84695-84704. PubMed ID: 27835897
[TBL] [Abstract][Full Text] [Related]
2. Association between transforming growth factor-β1 -509 C>T variants and hepatocellular carcinoma susceptibility: a meta-analysis.
Toshikuni N; Matsue Y; Minato T; Hayashi N; Tsutsumi M
Neoplasma; 2016; 63(6):961-966. PubMed ID: 27596296
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms of transforming growth factor-β1 associated with increased risk of gastric cardia adenocarcinoma in north China.
Guo W; Dong Z; Guo Y; Chen Z; Yang Z; Kuang G; Shan B
Int J Immunogenet; 2011 Jun; 38(3):215-24. PubMed ID: 21205231
[TBL] [Abstract][Full Text] [Related]
4. TGF-β1 -509C/T (or +869T/C) polymorphism might be not associated with hepatocellular carcinoma risk.
Li W; Wu H; Song C
Tumour Biol; 2013 Oct; 34(5):2675-81. PubMed ID: 23653379
[TBL] [Abstract][Full Text] [Related]
5. Association between TGF-β1 polymorphisms and hepatocellular carcinoma risk: a meta-analysis.
Guo Y; Zang C; Li Y; Yuan L; Liu Q; Zhang L; Li S
Genet Test Mol Biomarkers; 2013 Nov; 17(11):814-20. PubMed ID: 24016252
[TBL] [Abstract][Full Text] [Related]
6. TGF-β1 polymorphism 509 C>T is associated with an increased risk for hepatocellular carcinoma in HCV-infected patients.
Ma J; Liu YC; Fang Y; Cao Y; Liu ZL
Genet Mol Res; 2015 May; 14(2):4461-8. PubMed ID: 25966218
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta1 polymorphisms and breast cancer risk: a meta-analysis based on 27 case-control studies.
Qi X; Zhang F; Yang X; Fan L; Zhang Y; Chen L; Zhou Y; Chen X; Zhong L; Jiang J
Breast Cancer Res Treat; 2010 Jul; 122(1):273-9. PubMed ID: 20309626
[TBL] [Abstract][Full Text] [Related]
8. Role of TGF-beta1 (-509C>T) promoter polymorphism in susceptibility to cervical cancer.
Singh H; Jain M; Mittal B
Oncol Res; 2009; 18(1):41-5. PubMed ID: 19911703
[TBL] [Abstract][Full Text] [Related]
9. Circulating interleukin-6 and cancer: A meta-analysis using Mendelian randomization.
Tian G; Mi J; Wei X; Zhao D; Qiao L; Yang C; Li X; Zhang S; Li X; Wang B
Sci Rep; 2015 Jun; 5():11394. PubMed ID: 26096712
[TBL] [Abstract][Full Text] [Related]
10. Association of transforming growth factor-β1 gene C-509T and T869C polymorphisms with atherosclerotic cerebral infarction in the Chinese: a case-control study.
Peng Z; Zhan L; Chen S; Xu E
Lipids Health Dis; 2011 Jun; 10():100. PubMed ID: 21679448
[TBL] [Abstract][Full Text] [Related]
11. TGFB1 and TGFBR2 functional polymorphisms and risk of esophageal squamous cell carcinoma: a case-control analysis in a Chinese population.
Jin G; Deng Y; Miao R; Hu Z; Zhou Y; Tan Y; Wang J; Hua Z; Ding W; Wang L; Chen W; Shen J; Wang X; Xu Y; Shen H
J Cancer Res Clin Oncol; 2008 Mar; 134(3):345-51. PubMed ID: 17680270
[TBL] [Abstract][Full Text] [Related]
12. Association between circulating transforming growth factor-β1 level and polymorphisms in systemic lupus erythematosus and rheumatoid arthritis: A meta-analysis.
Lee YH; Bae SC
Cell Mol Biol (Noisy-le-grand); 2017 Feb; 63(1):53-59. PubMed ID: 28234629
[TBL] [Abstract][Full Text] [Related]
13. Influence of TGFB1 C-509T polymorphism on gastric cancer risk associated with TGF-β1 expression in the gastric mucosa.
Choi YJ; Kim N; Shin A; Lee HS; Nam RH; Chang H; Shin CM; Park YS; Lee DH; Park JH; Jung HC
Gastric Cancer; 2015 Jul; 18(3):526-37. PubMed ID: 25118995
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor- 1 C-509T polymorphism, oxidant stress, and early-onset childhood asthma.
Salam MT; Gauderman WJ; McConnell R; Lin PC; Gilliland FD
Am J Respir Crit Care Med; 2007 Dec; 176(12):1192-9. PubMed ID: 17673695
[TBL] [Abstract][Full Text] [Related]
15. Relationship between transforming growth factor-β1 and type 2 diabetic nephropathy risk in Chinese population.
Zhou T; Li HY; Zhong H; Zhong Z
BMC Med Genet; 2018 Nov; 19(1):201. PubMed ID: 30458730
[TBL] [Abstract][Full Text] [Related]
16. Circulating interleukin-6 and rheumatoid arthritis: A Mendelian randomization meta-analysis.
Li B; Xiao Y; Xing D; Ma XL; Liu J
Medicine (Baltimore); 2016 Jun; 95(23):e3855. PubMed ID: 27281095
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta1 gene C-509T and T869C polymorphisms as possible risk factors in rheumatic heart disease in Egypt.
Kamal H; Hussein G; Hassoba H; Mosaad N; Gad A; Ismail M
Acta Cardiol; 2010 Apr; 65(2):177-83. PubMed ID: 20458825
[TBL] [Abstract][Full Text] [Related]
18. Influence of transforming growth factor-β1 and tumor necrosis factor-α genes polymorphisms on the development of cirrhosis and hepatocellular carcinoma in chronic hepatitis C patients.
Radwan MI; Pasha HF; Mohamed RH; Hussien HI; El-Khshab MN
Cytokine; 2012 Oct; 60(1):271-6. PubMed ID: 22682513
[TBL] [Abstract][Full Text] [Related]
19. A correlational meta-analytical study of transforming growth factor-β genetic polymorphisms as a risk factor for chronic obstructive pulmonary disease.
He D; Li J; Zhou B; Chen Y; Hui Q; Ye F; Zhang L; He X; Niu W; Zhang Q
Gene; 2020 Jun; 744():144633. PubMed ID: 32240778
[TBL] [Abstract][Full Text] [Related]
20. Association between rs738409 polymorphism in patatin-like phospholipase domain-containing protein 3 (PNPLA3) gene and hepatocellular carcinoma susceptibility: Evidence from case-control studies.
Li JF; Zheng EQ; Xie M
Gene; 2019 Feb; 685():143-148. PubMed ID: 30403964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
